Churchill Capital CORP X/cayman Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE: Maverick Capital Sells Infleqtion Stake
Maverick Capital entities have significantly reduced their holdings in Infleqtion, Inc., selling over 8 million shares in late May 2026.
Maverick Capital Management and affiliated entities have filed a Schedule 13D, revealing a significant beneficial ownership of up to 9.2% in Infleqtion, Inc. common stock for investment purposes.
Churchill Capital Corp X has entered into a definitive merger agreement with ColdQuanta, Inc., supported by a $126.5 million PIPE investment and new governance agreements.
SCHEDULE 13D: Churchill Capital Corp X Sponsor Discloses 20.4% Stake Following IPO and Founder Share Adjustments
Churchill Sponsor X LLC and its affiliates, including CEO Michael Klein, have filed a Schedule 13D, revealing a 20.4% beneficial ownership stake in Churchill Capital Corp X, primarily through founder shares and private placement units acquired in connection with the company's recent Initial Public Offering.